- Home
- CCCC vs LFT Comparison
CCCC vs LFT Comparison
Compare CCCC & LFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- LFT
- Stock Information
- Founded
- CCCC 2015
- LFT 2012
- Country
- CCCC United States
- LFT United States
- Employees
- CCCC N/A
- LFT N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- LFT Real Estate Investment Trusts
- Sector
- CCCC Health Care
- LFT Real Estate
- Exchange
- CCCC Nasdaq
- LFT Nasdaq
- Market Cap
- CCCC 115.0M
- LFT 125.6M
- IPO Year
- CCCC 2020
- LFT N/A
- Fundamental
- Price
- CCCC $1.47
- LFT $2.58
- Analyst Decision
- CCCC Buy
- LFT Hold
- Analyst Count
- CCCC 3
- LFT 2
- Target Price
- CCCC $12.00
- LFT N/A
- AVG Volume (30 Days)
- CCCC 943.9K
- LFT 127.4K
- Earning Date
- CCCC 07-31-2025
- LFT 05-12-2025
- Dividend Yield
- CCCC N/A
- LFT 15.95%
- EPS Growth
- CCCC N/A
- LFT N/A
- EPS
- CCCC N/A
- LFT 0.20
- Revenue
- CCCC $39,783,000.00
- LFT $27,066,283.00
- Revenue This Year
- CCCC N/A
- LFT $177.59
- Revenue Next Year
- CCCC N/A
- LFT N/A
- P/E Ratio
- CCCC N/A
- LFT $12.91
- Revenue Growth
- CCCC 98.56
- LFT N/A
- 52 Week Low
- CCCC $1.09
- LFT $2.22
- 52 Week High
- CCCC $7.66
- LFT $2.84
- Technical
- Relative Strength Index (RSI)
- CCCC 51.01
- LFT 54.01
- Support Level
- CCCC $1.21
- LFT $2.46
- Resistance Level
- CCCC $1.57
- LFT $2.58
- Average True Range (ATR)
- CCCC 0.12
- LFT 0.08
- MACD
- CCCC 0.02
- LFT 0.01
- Stochastic Oscillator
- CCCC 70.27
- LFT 80.36
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About LFT Lument Finance Trust Inc.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.